4.6 Article

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Dermatology

Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial

Khaled Ezzedine et al.

Summary: This study evaluated the efficacy and safety of oral JAK3/TEC inhibitor ritlecitinib in patients with active nonsegmental vitiligo. The results showed that ritlecitinib demonstrated significant efficacy and good tolerability in treating vitiligo.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

Article Dermatology

Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): A double-blind, randomized, placebo-controlled, prospective, multicenter study

Samia M. Esmat et al.

Summary: This study aimed to evaluate the stabilizing effect of NB-UVB compared to systemic corticosteroids in skin photo-types (III-V) for vitiligo management. Despite earlier control of disease activity observed in the NB-OMP group, both groups showed comparable results by the end of the study. Disease activity prior to therapy, rather than extent, was found to influence control of activity in both groups.

PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2022)

Article Dermatology

Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS)

N. van Geel et al.

Summary: The study aimed to develop and validate the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS) to assess the evolution of vitiligo lesions over time. The results demonstrate that VDAS and VDIS are valid, reliable, and feasible instruments for evaluating vitiligo activity and improvement. These scores meet the urgent need for a simple, standardized, and practical assessment of vitiligo.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Article Medicine, General & Internal

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

David Rosmarin et al.

Summary: In two phase 3 trials, ruxolitinib cream showed greater repigmentation of vitiligo lesions compared to a vehicle control. However, it was associated with acne and pruritus at the application site.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Dermatology

Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial

K. S. Thomas et al.

Summary: For localized vitiligo, combination treatment with home-based handheld NB-UVB plus TCS is more effective than TCS alone, but successful in only around one-quarter of participants; participants with higher adherence during treatment were more likely to achieve treatment success, but the effects were lost once treatment stopped; combination treatment was relatively safe and well tolerated.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Article Dermatology

The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo

Hyun Jeong Ju et al.

Summary: This multicenter retrospective cohort study found that the long-term use of topical calcineurin inhibitors or phototherapy did not significantly increase the risk of developing lymphoma or skin cancer in vitiligo patients.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)

Article Dermatology

Analysis of Matched Skin and Gut Microbiome of Patients with Vitiligo Reveals Deep Skin Dysbiosis: Link with Mitochondrial and Immune Changes

Hanene Bzioueche et al.

Summary: The study found that patients with vitiligo had reduced richness and diversity of microbiota in stools compared to healthy controls, and skin swabs from lesional sites were primarily depleted of Staphylococcus compared with nonlesional sites. Biopsy microbiota from lesional skin showed distinct composition, depleted of protective bacteria but enriched in certain harmful bacteria.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Article Dermatology

Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: A 24-week prospective randomized placebo-controlled study

E. Fontas et al.

Summary: The study demonstrated that gliadin-protected SOD could be a beneficial addition to phototherapy in the treatment of vitiligo patients, showing a greater improvement in repigmentation compared to the placebo group at 24 weeks, with good tolerance in both groups and no reported side effects.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Review Dermatology

Association Between Topical Calcineurin Inhibitor Use and Risk of Cancer, Including Lymphoma, Keratinocyte Carcinoma, and Melanoma A Systematic Review and Meta-analysis

Megan Lam et al.

Summary: The systematic review and meta-analysis suggest an association between TCI use and lymphoma risk, but not with other cancers, with the potential increased risk likely very small for individual patients.

JAMA DERMATOLOGY (2021)

Review Immunology

Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective

Katia Boniface et al.

Summary: The process leading to melanocyte loss in vitiligo involves multiple factors such as environmental triggers, genetic polymorphisms, metabolic alterations, and autoimmunity. This review emphasizes on how danger signals released by stressed epidermal cells can trigger the immune system, ultimately leading to melanocyte disappearance.

FRONTIERS IN IMMUNOLOGY (2021)

Article Dermatology

Oral cyclosporine is effective in stabilizing active vitiligo: Results of a randomized controlled trial

Hitaishi Mehta et al.

Summary: The study compared the efficacy and safety of oral cyclosporine with OMP in treating active vitiligo, finding that both groups had similar proportions of patients achieving disease stabilization, but the group treated with oral cyclosporine achieved stabilization in a shorter period of time.

DERMATOLOGIC THERAPY (2021)

Article Dermatology

Is targeted UVB as effective as excimer light phototherapy in treatment of vitiligo?

Hera Tabassum et al.

Summary: The study compared the repigmenting efficacy and safety of Excimer light (EL) and targeted UVB (TUVB) devices in vitiligo treatment, revealing that EL demonstrated better repigmenting efficacy and both groups had minimal adverse effects.

DERMATOLOGIC THERAPY (2021)

Article Dermatology

Antibiotics Drive Microbial Imbalance and Vitiligo Development in Mice

Emilia R. Dellacecca et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)

Article Medicine, Research & Experimental

Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo

Nesrine Boukhedouni et al.

JCI INSIGHT (2020)

Article Health Care Sciences & Services

Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT

Jonathan M. Batchelor et al.

HEALTH TECHNOLOGY ASSESSMENT (2020)

Article Dermatology

Effect of combination NSAID and NBUVB treatment in non-photoadapters-A pilot study

Chintan Mehta et al.

PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2019)

Article Oncology

IL-17A is not a treatment target in progressive vitiligo

Reinhart Speeckaert et al.

PIGMENT CELL & MELANOMA RESEARCH (2019)

Letter Dermatology

Dermoscopy as an evolving tool to assess vitiligo activity

Abhijeet Kumar Jha et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

Article Dermatology

Motorized 0.8-mm micropunch grafting for refractory vitiligo: A retrospective study of 230 cases

Jung Min Bae et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)

Review Dermatology

Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis

R. Speeckaert et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)

Article Cell Biology

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo

Jillian M. Richmond et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Dermatology

Vitiligo and social acceptance

Reza Bidaki et al.

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2018)

Review Dermatology

Current and emerging treatments for vitiligo

Michelle Rodrigues et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Article Dermatology

The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo

Tasneem F. Mohammad et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Letter Dermatology

A cross-sectional, comparative study of home vs in-office NB-UVB phototherapy for vitiligo

Jean-Claire P. Dillon et al.

PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2017)

Review Dermatology

Home phototherapy in vitiligo

Tasneem F. Mohammad et al.

PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2017)

Article Oncology

Repigmentation in vitiligo: position paper of the Vitiligo; Global Issues Consensus Conference

Emily Y. Gan et al.

PIGMENT CELL & MELANOMA RESEARCH (2017)

Article Dermatology

Phototherapy and Combination Therapies for Vitiligo

Samia Esmat et al.

DERMATOLOGIC CLINICS (2017)

Article Dermatology

The Role of Diet and Supplements in Vitiligo Management

Pearl E. Grimes et al.

DERMATOLOGIC CLINICS (2017)

Letter Dermatology

Photolichenoid papules within vitiligo induced by narrowband UVB phototherapy

M. AlJasser et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)

Article Dermatology

Phototherapy: The vitiligo management pillar

Sarnia Esmat et al.

CLINICS IN DERMATOLOGY (2016)

Article Dermatology

Development and Validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative

Nanja van Geel et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

Review Dermatology

Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis

Laureline Legendre et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)

Article Medicine, General & Internal

Vitiligo

Mauro Picardo et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Article Dermatology

Laser (755nm) and cryotherapy as depigmentation treatments for vitiligo: a comparative study

N. van Geel et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)

Article Dermatology

Recent advances in childhood vitiligo

Nanette B. Silverberg

CLINICS IN DERMATOLOGY (2014)

Article Dermatology

Q-switched laser depigmentation in vitiligo, most effective in active disease

L. Komen et al.

BRITISH JOURNAL OF DERMATOLOGY (2013)

Article Dermatology

Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo

Osman Kose et al.

JOURNAL OF DERMATOLOGICAL TREATMENT (2010)

Article Dermatology

Oral dexamethasone pulse treatment for vitiligo

S Radakovic-Fijan et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)

Article Dermatology

Surgical techniques for vitiligo: A review

N van Geel et al.

DERMATOLOGY (2001)